Evaluation of artificial intelligence in the therapy of oropharyngeal squamous cell carcinoma - De-escalation via Claude 3 Opus, Vertex AI and ChatGPT 4.0?

Evaluation of artificial intelligence in the therapy of oropharyngeal squamous cell carcinoma - De-escalation via Claude 3 Opus, Vertex AI and ChatGPT 4.0? - HPV-AI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034390

Enrollment

200

Registered

2024-06-05

Start date

2024-05-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharyngeal squamous cell carcinoma (OPSCC)

Interventions

Group 1: Patients with oropharyngeal squamous cell carcinoma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Head and Neck Cancer

Exclusion criteria

Exclusion criteria: Other tumors

Design outcomes

Primary

Measure	Time frame
Therapy recommendation by AI/LLMs	—

Secondary

Measure	Time frame
Congruence with the MDT	—

Contacts

Public ContactBenedikt Schmidl

HNO Klinik, Klinikum rechts der Isar

benedikt.schmidl@tum.de08941405319

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026